Wellnex shelves low dose S3 move amid ‘remote’ chance of registration by Steve Jones June 11, 2024June 11, 2024 Wellnex Life has shelved plans to develop an over-the-counter cannabis product after concluding the chances of […]
Wellnex to launch range of cannabis medicine as more products enter market by Steve Jones June 5, 2024June 6, 2024
Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023April 30, 2024
Wellnex Life snaps up topical pain relief brand to complement medicinal cannabis strategy by Martin Lane May 29, 2023April 30, 2024
Company news: Wellnex Life; Creso Pharma; MGC Pharma; Zelira Therapeutics by Martin Lane March 16, 2023April 30, 2024
Company news: Releaf Group; Bod; Wellnex Life; MGC Pharma; MediCann Health by Martin Lane October 27, 2022April 29, 2024
Company news: Bod Australia; Cann Group; MediCann Health; MGC Pharma; Wellnex Life by Steve Jones and Martin Lane October 5, 2022April 29, 2024